The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121167163 12116716 3 F 20160913 20160225 20160915 EXP CA-009507513-1602CAN010290 MERCK 46.00 YR F Y 72.00000 KG 20160915 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121167163 12116716 1 PS JANUVIA SITAGLIPTIN PHOSPHATE 1 Oral UNK U 21995 FILM-COATED TABLET
121167163 12116716 2 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 600 MG, 1 EVERY 4 WEEKS U 0 600 MG
121167163 12116716 3 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 600 MG, 1 EVERY 4 WEEKS U 0 680 MG
121167163 12116716 4 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) UNK U 0
121167163 12116716 5 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 600 MG, 1 EVERY 4 WEEKS U 0 600 MG
121167163 12116716 6 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 616 MG, 1 EVERY 4 WEEKS U 0 616 MG
121167163 12116716 7 SS ACTEMRA TOCILIZUMAB 1 Intravenous (not otherwise specified) 672 MG, 1 EVERY 4 WEEKS U 0 672 MG
121167163 12116716 8 SS METFORMIN METFORMIN HYDROCHLORIDE 1 Oral UNK U 0
121167163 12116716 9 SS RAMIPRIL. RAMIPRIL 1 Oral 10 MG, UNK U 0 10 MG
121167163 12116716 10 SS RAMIPRIL. RAMIPRIL 1 Oral 5 MG, BID U 0 5 MG BID
121167163 12116716 11 C PANTOPRAZOLE SODIUM. PANTOPRAZOLE SODIUM 1 Unknown UNK U 0
121167163 12116716 12 C PREDNISONE. PREDNISONE 1 Unknown UNK U 0 TABLET
121167163 12116716 13 C RANITIDINE. RANITIDINE 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121167163 12116716 1 Diabetes mellitus
121167163 12116716 2 Rheumatoid arthritis
121167163 12116716 8 Diabetes mellitus
121167163 12116716 9 Hypertension

Outcome of event

Event ID CASEID OUTC COD
121167163 12116716 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121167163 12116716 Abdominal pain upper
121167163 12116716 Blood pressure systolic decreased
121167163 12116716 Bronchitis
121167163 12116716 Cough
121167163 12116716 Diarrhoea
121167163 12116716 Dizziness
121167163 12116716 Fatigue
121167163 12116716 Gastrointestinal disorder
121167163 12116716 Headache
121167163 12116716 Lower respiratory tract infection
121167163 12116716 Nasal congestion
121167163 12116716 Nasopharyngitis
121167163 12116716 Oropharyngeal pain
121167163 12116716 Respiratory tract congestion
121167163 12116716 Sinus congestion
121167163 12116716 Swelling face
121167163 12116716 Tooth disorder
121167163 12116716 Type 2 diabetes mellitus
121167163 12116716 Vomiting
121167163 12116716 Weight decreased
121167163 12116716 Weight fluctuation

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found